RecruitingPhase 2NCT04629547

Sleep Trial to Prevent Alzheimer's Disease


Sponsor

Washington University School of Medicine

Enrollment

200 participants

Start Date

May 25, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine if treatment with the sleep aid suvorexant can decrease the rate of amyloid-β (Aβ) accumulation in the brain.


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether treating sleep disorders — particularly sleep apnea — in older adults can reduce the risk of developing Alzheimer's disease. It focuses on people who currently show no signs of dementia, with the goal of preventing cognitive decline before it starts. **You may be eligible if...** - You are 65 years old or older - You currently show no signs of dementia (CDR score of 0) - You are willing and able to participate in study procedures, including a sleep test **You may NOT be eligible if...** - You have restless legs syndrome, narcolepsy, or other sleep disorders - You have untreated moderate-to-severe sleep apnea - You use a CPAP/sleep apnea device but use it less than 4 hours a night most nights - Your blood Alzheimer's biomarker test (p-tau 217) is below a certain threshold - You have had a stroke or have chronic kidney disease - You have liver problems or HIV - You have a history of substance or alcohol abuse in the past 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSuvorexant 20 mg

Suvorexant 20mg will be taken nightly for 24 months.

DRUGPlacebo

Placebo will be taken nightly for 24 months.


Locations(1)

Washington University School of Medicine

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04629547


Related Trials